TRIM33 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.304300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.397000E-01
Normal-vs-Stage2
2.556400E-02
Normal-vs-Stage3
1.281410E-01
Normal-vs-Stage4
6.232600E-01
Stage1-vs-Stage2
4.598200E-01
Stage1-vs-Stage3
3.903700E-02
Stage1-vs-Stage4
4.219800E-01
Stage2-vs-Stage3
1.232460E-04
Stage2-vs-Stage4
9.892500E-02
Stage3-vs-Stage4
4.988300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.096400E-02
Normal-vs-AfricanAmerican
4.240000E-01
Normal-vs-Asian
4.397900E-02
Caucasian-vs-AfricanAmerican
1.692640E-01
Caucasian-vs-Asian
6.102600E-01
AfricanAmerican-vs-Asian
1.873370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.109920E-02
Normal-vs-Female
5.841900E-02
Male-vs-Female
2.006400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.309200E-01
Normal-vs-Age(41-60Yrs)
1.199190E-01
Normal-vs-Age(61-80Yrs)
1.080030E-02
Normal-vs-Age(81-100Yrs)
1.333830E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.028200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.619200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.798600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.634200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.472000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.478600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.957400E-03
Normal-vs-Daily Drinker
1.198360E-02
Normal-vs-Weekly Drinker
1.199900E-02
Normal-vs-Occasional Drinker
1.283790E-01
Normal-vs-Social Drinker
1.448980E-01
Non Drinker-vs-Daily Drinker
7.911000E-01
Non Drinker-vs-Weekly Drinker
5.049800E-01
Non Drinker-vs-Occasional Drinker
4.831800E-02
Non Drinker-vs-Social Drinker
1.890640E-01
Daily Drinker-vs-Weekly Drinker
7.168400E-01
Daily Drinker-vs-Occasional Drinker
5.992200E-02
Daily Drinker-vs-Social Drinker
1.947400E-01
Weekly Drinker-vs-Occasional Drinker
4.572200E-02
Weekly Drinker-vs-Social Drinker
1.530000E-01
Occasional Drinker-vs-Social Drinker
7.293800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.132100E-02
Normal-vs-Grade 2
1.059510E-02
Normal-vs-Grade 3
1.200110E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.517200E-01
Grade 1-vs-Grade 3
5.285800E-01
Grade 1-vs-Grade 4
7.132100E-02
Grade 2-vs-Grade 3
9.705200E-01
Grade 2-vs-Grade 4
1.059510E-02
Grade 3-vs-Grade 4
1.200110E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.457300E-03
Normal-vs-NonDiabetic
1.050310E-02
Diabetic-vs-NonDiabetic
4.877800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.480300E-02
Normal-vs-NoPancreatitis
9.061600E-03
Pancreatitis-vs-NoPancreatitis
6.556000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.794100E-02
Normal-vs-N1
2.173900E-02
N0-vs-N1
7.396400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.224200E-02
Normal-vs-TP53-NonMutant
1.190020E-01
TP53-Mutant-vs-TP53-NonMutant
8.549600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
